Cantourage Group SE
ISIN: DE000A3DSV01
WKN: A3DSV0
05 November 2026 01:00PM

EQS-News: Cantourage Completes Third EU-GMP Certification Project and Secures Five-Year Exclusive Access to Premium Cannabis Products

Cantourage Group SE · ISIN: DE000A3DSV01 · EQS - Company News
Land: Deutschland · Primärmarkt: Deutschland · EQS News ID: 2429240

EQS-News: Cantourage Group SE / Key word(s): Strategic Company Decision/Agreement
Cantourage Completes Third EU-GMP Certification Project and Secures Five-Year Exclusive Access to Premium Cannabis Products

05.11.2026 / 13:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


  • Third strategic partner: With the successful EU-GMP certification of 1530076 BC Ltd., the exclusive processing partner of cannabis cultivators such as FN Canna, Cantourage has completed the certification of another internationally sought-after manufacturer of premium cannabis products, following Green Karat and LOT420.
  • Long-term competitive advantage: Through exclusivity agreements with established premium producers, Cantourage secures long-term exclusive access to high-quality cannabis products, further strengthening its competitive position in the European market.
  • Strong positioning in Europe: Leveraging its regulatory expertise, Cantourage is establishing itself as a key gateway to the European market for international premium producers.

Cantourage Group SE (hereinafter “Cantourage”, ISIN: DE000A3DSV01) is further strengthening its position in the European medical cannabis market. With the successful EU-GMP certification of Canadian licensed processor 1530076 BC Ltd., Cantourage has now successfully completed its third strategic certification project, following Green Karat and LOT420.

1530076 BC Ltd. operates production facilities in British Columbia, Canada, and provides production services to premium cannabis cultivators in the province, including 1235009 BC LTD d.b.a. FN Canna, a cultivator whose products are available under All Nations and Uncle Bob brands. Cantourage has represented FN Canna in the European market since 2023.

"This milestone belongs to our team. Achieving EU-GMP certification required months of rigorous preparation, documentation and process refinement, and our people met that challenge at every step. We are extremely proud of what they have accomplished. Our thanks also go to Cantourage, whose guidance and collaboration were instrumental in reaching this standard," says Hendrick Ng, Director of Quality of FN Canna.

“Following Green Karat and LOT420, 1530076 BC Ltd. is now the third partner we have successfully supported through the EU-GMP certification process. Through our exclusivity agreements, we have secured long-term access to a strategically important part of our premium portfolio, including our well-established All Nations products, but also many more premium cannabis products manufactured in British Columbia. This represents a significant strategic competitive advantage. At the same time, we are demonstrating that Cantourage's regulatory expertise not only opens the door to the European market for international premium producers, but also enables us to secure long-term access to some of the most sought-after products,” says Philip Schetter, CEO of Cantourage Group SE.

Through the long-term partnerships Cantourage has secured exclusive access to high-quality cannabis products from three internationally sought-after premium producers for a period of five years. This sustainably strengthens the company's competitive position while providing greater planning certainty regarding the availability of premium products that are in high demand.

About 1530076 BC Ltd.

1530076 BC Ltd. Is a joint venture between Phyton Biotech LLC and First Nations Processing Corporation and is a licensed processor of cannabis products based in British Columbia, Canada. Its EU-GMP certification (certificate no. DE-ST-01-GMP-2026-36) covers the processing, primary packaging and in-process quality control of medicinal cannabis flowers that have not been treated with ionizing radiation for microbial reduction. The certification confirms that the company's processing facility has been assessed as meeting the EU standard for good manufacturing practices applicable to medicinal cannabis. The company currently processes on behalf of its client 1235009 B.C. Ltd. d.b.a. FN Canna and intends to extend its processing services to further premium growers.

About Cantourage

Cantourage is a leading European company specializing in the production and distribution of cannabis-based medical preparations and pharmaceutical products. With its experienced management team and its “Fast Track Access” platform, Cantourage enables producers from around the world to enter the growing European medical cannabis market more quickly, easily and cost-effectively by processing and distributing their cannabis raw materials and extracts. In doing so, Cantourage consistently ensures compliance with the highest European pharmaceutical quality standards. The company offers pharmaceutical-grade products across all relevant market segments: dried cannabis flower, extracts, dronabinol and cannabidiol. Cantourage was listed on the Frankfurt Stock Exchange on 11 November 2022 (ISIN: DE000A3DSV01).

 

 

 



05.11.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Cantourage Group SE
Feurigstraße 54
10827 Berlin
Germany
E-mail: info@cantourage.com
Internet: https://www.cantourage.com/
ISIN: DE000A3DSV01
WKN: A3DSV0
Listed: Regulated Unofficial Market in Dusseldorf, Frankfurt (Scale), Munich, Stuttgart, Tradegate BSX
LEI Code: 3912003NCTLO6YHA9V48
EQS News ID: 2429240

 
End of News EQS News Service

2429240  05.11.2026 CET/CEST

Zur besseren Einschätzung der fundamentalen Entwicklung der jeweiligen Unternehmen bietet boersengefluester.de (BGFL) eine Übersicht mit den wesentlichen Kennzahlen zu Umsatz, Ergebnis, Cashflow und Dividende. Sämtliche Angaben werden manuell in unserer Datenbank erfasst – Quelle sind die jeweiligen Geschäftsberichte. Sofern es sich um Schätzungen für künftige Zahlen handelt, stammen sie durchweg von BGFL. 

Die wichtigsten Finanzdaten auf einen Blick
  2020 2021 2022 2023 2024 2025 2026e
Umsatzerlöse1 0,53 5,22 14,16 23,56 50,91 92,80 90,00
EBITDA1,2 -0,56 -0,83 -2,51 -0,25 3,48 5,70 11,00
EBITDA-Marge3 -105,66 -15,90 -17,73 -1,06 6,84 6,14 12,22
EBIT1,4 -0,59 -0,97 -6,32 -4,33 -0,72 4,00 0,00
EBIT-Marge5 -111,32 -18,58 -44,63 -18,38 -1,42 4,31 0,00
Jahresüberschuss1 -0,59 -0,97 -5,92 4,27 -1,14 3,00 0,00
Netto-Marge6 -111,32 -18,58 -41,81 18,12 -2,24 3,23 0,00
Cashflow1,7 -0,56 -0,83 -2,11 -0,20 3,07 6,00 0,00
Ergebnis je Aktie8 -0,05 -0,08 -0,47 -0,34 -0,09 0,24 0,31
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben
Legende

1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PKF Wulf Gruppe

Alle relevanten Bewertungskennzahlen, Termine und sonstige Investor-Informationen zu Ihrer Aktie kompakt zusammengefasst. Gut zu wissen: Sämtliche Daten stammen von boersengefluester.de werden täglich aktualisiert. Damit sind Sie immer auf dem neuen Stand. Kurze Erkärungen zu den Kennzahlen bekommen Sie, wenn Sie mit dem Cursor bzw. der Maus auf das jeweilige Feld gehen.

INVESTOR-INFORMATIONEN
©boersengefluester.de
Cantourage Group
WKN ISIN Rechtsform Börsenwert IPO Einschätzung Plus Code
A3DSV0 DE000A3DSV01 SE 55,61 Mio € 11.11.2022 Kaufen 9F4MF9M4+93
* * *
KGV 2027e KGV 10Y-Ø BGFL-Ratio Shiller-KGV KBV KCV KUV
11,74 14,26 0,82 -44,60 1,43 18,14 0,60
Dividenden
Dividende '2024
in €
Dividende '2025
in €
Dividende '2026e
in €
Div.-Rendite '2026e
in %
0,00 0,00 0,00 0,00%
Finanztermine
Hauptversammlung Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
24.06.2026 11.05.2026 13.08.2026 10.11.2026 15.05.2026
Performance-Angaben
Abstand 60-Tage-Linie Abstand 200-Tage-Linie Performance YtD Kursveränderung 52 Wochen IPO
Akt. Kurs (EoD)
+0,22%
4,46 €
ATH 40,50 €
-16,48% -18,43% +31,56% +52,22% -31,17%

Werbung ist für uns ein wichtiger Einnahmekanal. Aber wir verstehen, dass sie manchmal lästig wird. Wenn Sie die Anzahl der angezeigten Werbung reduzieren möchten, loggen Sie sich einfach in Ihr Benutzerkonto ein und verwalten Sie die Einstellungen von dort aus. Als registrierter Benutzer erhalten Sie viele Vorteile.
          Qualitätsjournalismus · 2013-2026 · Made in Germany          
Die Analyse-Manufaktur

Informierte Anleger treffen bessere Entscheidungen

Auf dem 2013 von Gereon Kruse gegründeten Finanzportal boersengefluester.de dreht sich alles um deutsche Aktien – mit klarem Schwerpunkt auf Nebenwerte. Neben klassischen redaktionellen Beiträgen sticht die Seite insbesondere durch eine Vielzahl an selbst entwickelten Analysetools hervor. Basis sämtlicher Tools ist eine komplett selbst gepflegte Datenbank für mehr als 650 Aktien. Damit erstellt boersengefluester.de Deutschlands größte Gewinn- und Dividendenprognose.

Kontakt

Idee & Konzept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2026 von Gereon Kruse #BGFL